BLIS Technologies Full Year 2025 Earnings: EPS: NZ$0.001 (vs NZ$0.001 in FY 2024)

Advertisement

BLIS Technologies (NZSE:BLT) Full Year 2025 Results

Key Financial Results

  • Revenue: NZ$13.1m (up 13% from FY 2024).
  • Net income: NZ$838.0k (up 30% from FY 2024).
  • Profit margin: 6.4% (up from 5.6% in FY 2024). The increase in margin was driven by higher revenue.
  • EPS: NZ$0.001 (in line with FY 2024).
earnings-and-revenue-history
NZSE:BLT Earnings and Revenue History May 22nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

BLIS Technologies shares are up 14% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for BLIS Technologies (1 makes us a bit uncomfortable) you should be aware of.

Valuation is complex, but we're here to simplify it.

Discover if BLIS Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NZSE:BLT

BLIS Technologies

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.

Flawless balance sheet with low risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.9% undervalued
21 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17044.9% undervalued
42 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38033.4% undervalued
26 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative

Updated Narratives

DA
davidlsander
SALT logo
davidlsander on Atlas Salt ·

Once In A Life Time Deeply Discounted Recession Proof Utility

Fair Value:CA$2.9660.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PI
PittTheYounger
SSAB A logo
PittTheYounger on SSAB ·

SSAB in pole position when it comes to the combination of steel tariffs and the EU's investment drive

Fair Value:SEK 79.1721.8% overvalued
63 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
CH
XIFR logo
ChuckN on XPLR Infrastructure ·

Investor Thesis: Why XPLR Infrastructure Could Be Deeply Undervalued in an AI Power Cycle

Fair Value:US$56697.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.6% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1933.2% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative